Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Syndax Pharmaceuticals Q2 EPS $(0.62) Down From $(0.44) YoY

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share. This is a 40.91 percent decrease over losses of $(0.44) per share from the same period last year.
byBenzinga Newsdesk
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share. This is a 40.91 percent decrease over losses of $(0.44) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts